Navigation Links
Scientists obtain anticancer medicines from the elecampe, a wild plant growing in the Mediterranean

This release is available in Spanish.

A group of scientists from the Department of Organic Chemistry and the Biotechnology Institute of the University of Granada have found out that the plant Dittirichia viscose, known as elecampe, can be used to obtain inhibitors of neurogenic vasodilatation, a significant progress in migraine and cancer treatments.

The study, supervised by professors Mara del Mar Herrador and Alejandro Fernndez Barrero, has been carried out by Julieta Vernica Cataln, assistant professor of the National University of Tucuman (Argentina) and researcher of the University of Granada, and it has been financed by the Unin Europea through the Programa Alban and the Ministerio de Ciencia y Tecnologa. Julieta Vernica used the elecampe plant, abundant in the Mediterranean area, to obtain a method for taking out and purifying a natural product known as ilicic acid.

A promising angiogenesis inhibitor

This acid has been used to develop an effective method of chemical synthesis and of industrial interest towards the pharmacologically active &-eudesmol (against migraine) and -eudesmol which inhibits in vivo selectively, the proliferation of endothelial cells, being a promising antiangiogenic.

Likewise, these researchers have made another important discovery: they have used the germacrona compound, obtained from the Baccharis latifolia, a plant growing in the Bolivian Andes, in a new chemical synthesis of the antitumoral -element. This natural product serves to inhibit selectively the vascular endothelial brain cells and it has been used as an agent to prevent cancer in brain tumours and metastases from brain and lung cancer, preventing its growth. Besides, it has been proved that it leads to apoptosis and stops the cellular differentiation process and inhibits neoplasm metastases, so it can be used in lung neoplasm chemotherapy as well as in colon, stomach or brain chemotherapy, etc. There are several patented formulas for its use alone or combined with other agents such as taxol, 5- Fu or stemmed from cisplatin.


Contact: Alejandro Fernndez Barrero
Universidad de Granada

Related medicine news :

1. Jefferson scientists discovery may help explain smoking-pancreatic cancer link
2. With annual deaths from malaria on the rise: Scientists ask where is all the money going?
3. Stem cells and cancer: Scientists investigate a fine balancing act
4. Scientists Block Prostate Cancer Cells Spread
5. Scientists solve mystery of polyketide drug formation
6. Scientists Uncover How HIV Hides Inside Cells
7. Scientists: New technique identifies molecular biomarkers for disease
8. Princeton Professor David W. C. MacMillan Lectured WuXi PharmaTech Scientists
9. NewYork-Presbyterian/Columbia physician-scientists present at ACCs 57th Annual Scientific Session
10. Dental scientists convene in Dallas
11. Eminent scientists to lecture in Dallas
Post Your Comments:
(Date:6/27/2016)... (PRWEB) , ... June 27, 2016 , ... ... cutting edge technology to revolutionize the emergency ambulance transport experience for the millions ... aware of how Uber has disrupted the taxi industry through the use of ...
(Date:6/26/2016)... ... , ... Pixel Film Studios Released ProSlice Levels, a Media Slicing Effect ... a whole new perspective by using the title layers in ProSlice Levels to ... ProSlice Levels contains over 30 Different presets to choose from. FCPX users ...
(Date:6/25/2016)... ... June 25, 2016 , ... Experts from the ... AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the Hynes Convention Center in ... topics including advance care planning, healthcare costs and patient and family engagement. , ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room , ... Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. , ... our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of First ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits of moderation, whether ... latter, setting the bar too high can result in disappointment, perhaps even self-loathing. However, ... their goal. , Research from reveals that behind the tendency ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that it ... (procalcitonin) assay as a dedicated testing solution for people ... Roche is the first IVD company in the U.S ... assessment and management. PCT is a sepsis-specific ... blood can aid clinicians in assessing the risk of ...
(Date:6/23/2016)... , June 23, 2016 Bracket , ... launch its next generation clinical outcomes platform, Bracket eCOA (SM) ... held on June 26 – 30, 2016 in ... first electronic Clinical Outcome Assessment product of its kind to ... #715. Bracket eCOA 6.0 is a flexible platform ...
(Date:6/23/2016)... 23, 2016 Revolutionary technology includes ... Oticon , industry leaders in advanced audiology and hearing ... Oticon Opn ™, the world,s first internet connected hearing ... IoT devices.      (Photo: ... number of ,world firsts,: , TwinLink™ - ...
Breaking Medicine Technology: